Hammon K, Renner K, Althammer M, Voll F, Babl N, Decking S-M, Siska PJ, Matos C, Conejo ZEC, Mendes K, Einwag F, Siegmund H, Iberl S, Berger RS, Dettmer K, Schoenmehl R, Brochhausen C, Herr W, Oefner PJ, Rehli M, Thomas S, Kreutz M. D-2-hydroxyglutarate supports a tolerogenic phenotype with lowered major histocompatibility class II expression in non-malignant dendritic cells and acute myeloid leukemia cells. haematol [Internet]. 2024Aug.1 [cited 2024Nov.24];109(8):2500-14. Available from: https://haematologica.org/article/view/haematol.2023.283597